Effect of Medicaid Expansion on Colorectal Cancer Screening Rates.


Journal

Diseases of the colon and rectum
ISSN: 1530-0358
Titre abrégé: Dis Colon Rectum
Pays: United States
ID NLM: 0372764

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 9 11 2018
medline: 12 3 2019
entrez: 9 11 2018
Statut: ppublish

Résumé

Colorectal cancer screening decreases incidence and improves survival. Minorities and low-income patients have lower screening rates. The Affordable Care Act increased insurance coverage for low-income Americans by funding Medicaid expansion. Not all states expanded Medicaid. The effect of Medicaid expansion on colorectal cancer screening is unknown. This study aimed to evaluate if Medicaid expansion improved colorectal cancer screening for minorities and low-income patients. We used the Behavior Risk Factor Surveillance System, a nationally representative health-related telephone survey, to compare colorectal cancer screening rates from 2012 to 2016 based on Medicaid expansion status. A difference-in-difference analysis was used to compare the trends. All states were included in this survey. Respondents aged 50 to 64 from the early expansion, 2014 expansion, and nonexpansion states were selected. Medicaid expansion was funded by the Affordable Care Act. The primary outcome measured was the screening rate based on US Preventive Services Task Force guidelines. Overall screening in expansion states increased (early, +4.5%, p < 0.001; 2014, +1.3%, p = 0.17) compared with nonexpansion states. Screening among low-income respondents increased in early expansion states (+5.7%; p = 0.003), whereas there was no change in 2014 expansion states compared with nonexpansion states (2014, -0.3%, p = 0.89). For blacks, there was a significant increase in early expansion states, but no change in 2014 expansion states (early, +8.1%, p = 0.045; 2014, -1.5%, p = 0.64). There was no significant change for Hispanic respondents in early or 2014 expansion states compared with nonexpansion states (early, +6.5%, p = 0.11; 2014, +1.2%, p = 0.77). Survey data are subject to response and recall bias. Factors other than Medicaid expansion may have influenced the screening rate. The colorectal cancer screening rate has increased in all settings, but expansion accelerated the increases in early expansion states and among low-income and black respondents; however, there was no similar increase for Hispanic respondents. It will be important to continue to monitor the effects of Medicaid expansion on colorectal cancer care, especially the incidence by stage and mortality. See Video Abstract at http://links.lww.com/DCR/A792.

Sections du résumé

BACKGROUND
Colorectal cancer screening decreases incidence and improves survival. Minorities and low-income patients have lower screening rates. The Affordable Care Act increased insurance coverage for low-income Americans by funding Medicaid expansion. Not all states expanded Medicaid. The effect of Medicaid expansion on colorectal cancer screening is unknown.
OBJECTIVE
This study aimed to evaluate if Medicaid expansion improved colorectal cancer screening for minorities and low-income patients.
DESIGN
We used the Behavior Risk Factor Surveillance System, a nationally representative health-related telephone survey, to compare colorectal cancer screening rates from 2012 to 2016 based on Medicaid expansion status. A difference-in-difference analysis was used to compare the trends.
SETTINGS
All states were included in this survey.
PATIENTS
Respondents aged 50 to 64 from the early expansion, 2014 expansion, and nonexpansion states were selected.
INTERVENTIONS
Medicaid expansion was funded by the Affordable Care Act.
MAIN OUTCOME MEASURES
The primary outcome measured was the screening rate based on US Preventive Services Task Force guidelines.
RESULTS
Overall screening in expansion states increased (early, +4.5%, p < 0.001; 2014, +1.3%, p = 0.17) compared with nonexpansion states. Screening among low-income respondents increased in early expansion states (+5.7%; p = 0.003), whereas there was no change in 2014 expansion states compared with nonexpansion states (2014, -0.3%, p = 0.89). For blacks, there was a significant increase in early expansion states, but no change in 2014 expansion states (early, +8.1%, p = 0.045; 2014, -1.5%, p = 0.64). There was no significant change for Hispanic respondents in early or 2014 expansion states compared with nonexpansion states (early, +6.5%, p = 0.11; 2014, +1.2%, p = 0.77).
LIMITATIONS
Survey data are subject to response and recall bias. Factors other than Medicaid expansion may have influenced the screening rate.
CONCLUSIONS
The colorectal cancer screening rate has increased in all settings, but expansion accelerated the increases in early expansion states and among low-income and black respondents; however, there was no similar increase for Hispanic respondents. It will be important to continue to monitor the effects of Medicaid expansion on colorectal cancer care, especially the incidence by stage and mortality. See Video Abstract at http://links.lww.com/DCR/A792.

Identifiants

pubmed: 30407931
doi: 10.1097/DCR.0000000000001260
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-103

Auteurs

Yasmin A Zerhouni (YA)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
UCSF East Bay Department of Surgery, Oakland, California.

Quoc-Dien Trinh (QD)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Division of Urological Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Stuart Lipsitz (S)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.

Joel Goldberg (J)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Section of Colon and Rectal Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Jennifer Irani (J)

Section of Colon and Rectal Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Ronald Bleday (R)

Section of Colon and Rectal Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Adil H Haider (AH)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.

Nelya Melnitchouk (N)

Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, Massachusetts.
Section of Colon and Rectal Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH